Ivenix announced today that it is partnering with The AAMI Foundation’s Healthcare Technology Safety Institute (HTSI) to support The National Coalition for Infusion Therapy Safety. This two-year initiative is planning to address ongoing patient safety issues identified in 2010 at the AAMI/FDA Infusion Device Summit. The coalition is made up of national organizations, healthcare technology vendors, researchers, and providers.
The AAMI Foundation states that the Coalition has two goals:
“First, to bring together pioneering hospitals, researchers, professional societies, industry, and other national leaders in infusion safety to agree upon evidence-based solutions to several key issues contributing to poor patient outcomes with infusion therapy. Second, to promote those solutions nationwide. “
Marilyn Neder-Flack, Executive Director of the AAMI Foundation, noted, “We will spend the next two years disseminating the recommendations the coalition produces and providing educational materials and proven implementation methods so hospitals can employ the recommendations. This may help save 5,000 hospitals from developing infusion-related safety techniques, education and methods in their own silos, and to help move the country to some standardization in how infusion therapy is administered, where possible.”
Additionally, Flack notes, “This type of long-term, intense, committed effort takes all stakeholders working together, and would not be possible without the support Ivenix and the other industry partners have given the AAMI Foundation.”
Ivenix will be participating in The Coalition Kick-off Event March 12-13, 2015. This invitational stakeholder meeting will bring together hospitals, patient advocates, representatives from national associations & societies, and industry-partners to build consensus, share techniques to increase drug library compliance, provide education strategies for multiple line therapy and methods to reduce non-clinically actionable infusion-related alarms.
“We are proud to partner with the AAMI Foundation to support The National Coalition for Infusion Therapy Safety” said John Sokolowski, Vice President of Regulatory & Quality Assurance at Ivenix. “This is an important patient safety initiative and we are pleased to see key stakeholder organizations and providers coming together with industry to collaboratively develop recommendations to address these ongoing issues.”
Additional information on The Coalition can be found at aami.org.